Fresenius Stock Today

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>FM</div>
Fresenius Medical is selling at 41.56 as of the 28th of May 2020; that is 2.57 percent increase since the beginning of the trading day. The stock's lowest day price was 41.51. Fresenius Medical has about a 39 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 30 trading days. Equity ratings for Fresenius Medical Care are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 28th of February 2020 and ending today, the 28th of May 2020. Click here to learn more.
Analyze Filter   Fiscal Quarter End: 30th of June 2020

  Performance4 100 

Fresenius Medical Profile

Next fiscal quarter end is expected on 30th of June 2020. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical operates under Medical Care Facilities classification in USA and is traded on BATS Exchange. It employs 121403 people. more on Fresenius Medical
Fresenius Medical Fama & French Healthcare
Fama & French Classification
Fresenius Medical Care SEC Filings
Fresenius Medical SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameFresenius Medical Care
CEOKent WanzekView All
Thematic Classification
Currently Active Investing Idea
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Fresenius Medical Care. The Fresenius consensus assessment is calculated by taking the average estimates from all of the analysts covering Fresenius Medical
Piotroski F Score
Academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Fresenius Medical Care financial position. Scores of 8 and 9 are usually clasified strong value stocks whereas scores of 2 or below are considered weak value stocks.
5 - Current Score Healthy
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares600.9 M306.9 M
Way Up
Slightly volatile
Net Cash Flow from Operations1.1 B2.6 B
Way Down
Total Assets25.5 B32.9 B
Significantly Down
Slightly volatile
Total Liabilities17.9 B19.7 B
Significantly Down
Slightly volatile
Current AssetsB7.2 B
Fairly Down
Slightly volatile
Current Liabilities4.2 BB
Way Down
Slightly volatile
Total Debt8.6 B13.8 B
Way Down
Slightly volatile
Return on Average Assets0.04370.041
Notably Up
Gross Margin0.30050.309
Fairly Down
Slightly volatile
Asset Turnover0.59130.591
Slightly Up
Slightly volatile
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Fresenius Medical available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Cautious HoldFairly Valued
Financial Strength
Fresenius Medical financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Fresenius Medical success along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
  Operating Cash Flow
Fresenius Medical Care (FMS) is traded on BATS Exchange in USA. It is located in Else-Kroner Strasse 1 and employs 121,403 people. Fresenius Medical is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 21.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresenius Medical's market, we take the total number of it shares issued and multiply it by the Fresenius Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Fresenius Medical Care runs under Healthcare sector within Medical Care Facilities industry. The entity has 600.88 M outstanding shares of which 445.26 K shares are currently shorted by investors with about 0.72 days to cover shorted positions. FRESENIUS MED ADS has about 2.04 B in cash with 1.08 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.33.
Check Fresenius Medical Probability Of Bankruptcy

Ownership Allocation (%)

Fresenius Stock Price Odds Analysis

Odds Down 41.56HorizonTargetOdds Up 41.56
93.82%30 days
Based on normal probability distribution, the odds of Fresenius Medical to move above current price in 30 days from now is about 6.13 (This Fresenius Medical Care probability density function shows the probability of Fresenius Medical Stock to fall within a particular range of prices over 30 days) .

Fresenius Stock Institutional Holders

InstituionSecurity TypeTotal SharesValue
Morgan StanleyCommon Shares1.4 M46.4 M
Bank Of America CorpCommon Shares698.9 K22.9 M
View Fresenius Medical Diagnostics

Fresenius Medical Income Statement Over Time

Fresenius Medical Care Income Statement is one of the three primary financial statements used for reporting Fresenius's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fresenius Medical Care revenue and expense. Fresenius Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period. Fresenius Medical Operating Expenses is relatively stable at the moment as compared to the last year. Fresenius Medical reported last year Operating Expenses of 3.2 Billion. As of 05/28/2020, Operating Income is likely to grow to about 2.4 B, while Net Income to Non Controlling Interests is likely to drop slightly above 234 M. View More Fundamentals
Consolidated Income    Interest Expense    Net Income    

Fresenius Stock Against Markets

Did you try this?

Run Stock Tickers Now


Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Fresenius Medical Upcoming and Recent Events

Fresenius Medical Company Earnings Announcements Dates

Upcoming Quarterly Report4th of August 2020
Next Earnings Report3rd of November 2020
Next Fiscal Quarter End30th of June 2020
Next Fiscal Year End18th of February 2021
Last Quarter Report31st of March 2020
Last Earning Anouncement30th of June 2019

Fresenius Medical Corporate Filings

Fresenius Medical SEC Reporting

Other Events
Unclassified Corporate Event

Fresenius Medical Distributions to stockholders

Fresenius Medical Corporate Management

Roberto Fuste Member of the Management Board for Asia-Pacific
Walter Weisman Member of the Supervisory Board
Pascale Witz Independent Member of the Supervisory Board
Deborah McWhinney Member of the Supervisory Board
Please check Investing Opportunities. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page